SCHEMBL23997157

SCHEMBL23997157

CC(C)(C)Cn1nc(-c2ccc(N)cc2)c2c(N)ncnc21

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.83
▸ KDM4E B2RXH2 3/20 0.83
▸ MAPK1 P28482 2/20 0.83
▸ TP53 P04637 1/20 0.83
▸ CYP3A4 P08684 1/20 0.83
▸ MEN1 O00255 1/20 0.81
▸ KMT2A Q03164 1/20 0.81
▸ TDP1 Q9NUW8 1/20 0.81
▸ BTK Q06187 4/20 0.58
▸ FYN P06241 7/20 0.54
▸ SRC P12931 5/20 0.54
▸ ABL1 P00519 3/20 0.54
▸ YES1 P07947 3/20 0.54
▸ RIPK2 O43353 3/20 0.54
▸ RET P07949 2/20 0.54
▸ ALDH1A1 P00352 2/20 0.54
▸ EGFR P00533 2/20 0.54
▸ LMNA P02545 2/20 0.54
▸ LCK P06239 2/20 0.54
▸ LYN P07948 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13019782 0.90 CYP1A2 (1.00) CYP1A2KDM4EMAPK1TP53CYP3A4
SCHEMBL24096881 0.90 CYP1A2 (0.68) CYP1A2KDM4EMAPK1TP53CYP3A4
SCHEMBL23997251 0.83 CYP1A2 (0.69) CYP1A2KDM4EMAPK1TP53CYP3A4
SCHEMBL409444 0.80 SRC (0.82) CYP1A2KDM4EBTKFYNSRC
SCHEMBL16492482 0.79 CYP1A2 (0.63) CYP1A2KDM4EMAPK1TP53CYP3A4
SCHEMBL1320126 0.78 SRC (0.55) CYP1A2KDM4EMAPK1TP53CYP3A4
SCHEMBL12366 0.77 NUDT14 (0.69) CYP1A2KDM4EBTKFYNSRC
SCHEMBL12120630 0.77 CYP1A2 (0.53) CYP1A2KDM4EMAPK1TP53CYP3A4
SCHEMBL23997135 0.77 CYP1A2 (0.60) CYP1A2KDM4EMAPK1TP53CYP3A4
SCHEMBL20533043 0.77 CYP1A2 (0.61) CYP1A2KDM4EMAPK1TP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021226547-A2 TARGETED NEK7 INHIBITION FOR MODULATION OF THE NLRP3 INFLAMMASOME Halia Therapeutics, Inc. (US) 2021-11-11 — — WO disclosed
Send feedback